Immunogenicity after two and three doses of mRNA vaccine in patients with cancer treated with exclusive radiotherapy.
Scoccianti S, Delli Paoli C, Infantino M, Paoletti L, Caini S, Meacci F, Russo S, Esposito M, Fondelli S, Grilli Leonulli B, Grossi V, Barca R, Alpi P, Furlan F, Perna M, Pino MS, Martella F, Manfredi M, Stefanacci M, Bassetti A, Casprini P, Fioretto L.
Scoccianti S, et al. Among authors: casprini p.
Int Immunopharmacol. 2023 Sep;122:110460. doi: 10.1016/j.intimp.2023.110460. Epub 2023 Jun 29.
Int Immunopharmacol. 2023.
PMID: 37392566